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Abstract
Background: Breast cancer is recognised as a major public health problem in developing countries; however, there
is very limited evidence about its epidemiology in the Central African Republic. The aim of this study was to investigate
the epidemiological and histopathological characteristics of breast cancer in Bangui.
Methods: This is a retrospective study based on the data collected from pathological anatomy records from 2003 to
2015 in Bangui. A questionnaire was designed to collect information and data was analysed using descriptive and
inferential statistical methods.
Results: The mean age was 45.83 (SD = 13.5) years. The age group of 45–54 years represented the majority of the
study population (29.3%). Over 69.5% of the women were housewives with a moderate economic status (56.9%).
Less than 14% of the study population had a level of academic degree and 85.6% lived in cities. The breast cancer
prevalence was 15.27%. The age-standardized incidence and death by world population (ASW) were 11.19/100,000 and
9.97/100,000 respectively. 50–54 years were most affected. Left breast cancer is mainly common and the time between
first symptoms and consultation is more than 48 months. Most (69%) of the samples analysed were lumpectomy.
The most common morphology of breast cancer was invasive ductal carcinoma (64.9%). Scarff Bloom Richardson III
was the main grade in both common pathological types, but their proportion showed no significant increase along
with time (χ2 = 7.06, p = 0.54). Invasion of regional lymph node differed significantly among the pathological type of
breast cancer (χ2 = 24.6, p = 0.02). Surgery and chemotherapy were appropriate treatment yet 84.5% of the cases died.
Conclusion: The findings of this study showed that breast cancer is common and mostly affected women.
Epidemiological trends are more or less common to those of developing countries with a predominance of invasive
ductal carcinoma. However, most of the women studied live in an urban area and developed the disease in advanced
stage. The establishment of an appropriate framework will effectively contribute to promoting the early detection and
reducing the incidence of this disease in the population.
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Background
Breast cancer (BC) is a common form of cancer among
women globally. It’s the fifth leading cause of death with
an average of 522,000 cases per year [1]. Currently, it is
the most leading cause of cancer death with 198,000
deaths per annum which represents 15.4% of all deaths
in developed regions after that of the lung cancer [2]. In
developing countries, it is the first leading cause of death
among women with 324,000 deaths which represented
14.3% of all deaths [2, 3]. Moreover, this rate varied from
6 to 20 per 100,000 in East Asia and West Africa as a
whole [4].
In 2012, the number of new cases diagnosed in women
was 1.7 million (25% of all cancers), with more cases ob-
served in the developed regions (883,000 cases against
794,000 in developing countries) [4, 5]. Incidence rates
almost quadrupled from one region to another through-
out the world [4]. In 2012, the incidence rate in Africa
and East Asia was 27 per 100,000, while in Europe it
was 96 per 100,000 [4]. In 2011, the annual incidence
rate in Sub-Saharan African (SSA) was 22 per 100,000
women [6]. The age distribution of the incidence of BC
allows to objectifying a high incidence increased from
35 years, peaking at 60 [7].
The burden of the diseases caused by BC is important.
However, BC etiology is far from being fully understood
in developing countries such as Central African Republic
(CAR). Large differences have been observed in the be-
haviour of the tumour, clinical manifestation, treatment
response and prognosis [8].
According to WHO recent report estimates, the breast
cancer-related mortality was the leading cause of death
(24.5%) among Central African women in 2012 [9, 10].
The mortality rate of BC varies proportionally with age.
It also depends on the stage of disease diagnosis, the speed
of management, type and extent of the tumour, com-
placency and response to initial treatment. The main
risk factors related to BC are hormonal factors related
to pre-menopausal estrogenic impregnation, genetic
predispositions, related factors behaviours and envir-
onmental factors [11].
In recent decades, CAR started to record a significant
reduction in infectious diseases through the various na-
tional programs established. There was an epidemio-
logical transition marked by demographic change, with
an increase of life expectancy (50 years for men and
52 years for women), a transformation of the environ-
ment, and changes in lifestyle [9].
From this emerged, the new pathologies including can-
cer and other chronic non-communicable diseases which
fall among the new priority public health needs [12].
Some studies have reported the clinical and pathological
features of women BC in the CAR; however, there is no
concrete evidence about the epidemiology of BC in the
population [13–15]. Hence, the management of BC has
become a major problem of public health which requires
special attention from the ministry of health [16].
This study was conducted to address the lack of epi-
demiological evidence on BC, the absence of an oper-
ational plan for the fight against cancer and the lack of a
support structure as well as national registry, with the
main aim to understand the epidemiological characteris-
tics of BC among women over 15 years old living in
Bangui and to identify clinical histopathological trends
in the last 12 years (2003–2015).
Methods
Study population
This was retrospective study based on the primary data
collected through patient’s recorders from the patho-
logical anatomy laboratory, surgical and gynecology
services. The cases were confirmed by histological or
cytological analysis during the study period. The follow-
ing conditions were excluded: aged < 15 years old, not
residing in CAR territory, and all those whose patho-
logical diagnosis date was outside the study period. Re-
search was approved by the Institutional Review Board
of the School of Public Health, Tongji Medical College
of Huazhong University of Science and Technology
(IRB Approval File No.[2014] 09), and University of
Bangui (No 2068/UB/FACSS/CSCVPER/16). Patient
consent was not required due to the retrospective na-
ture of this study.
Data collection
A questionnaire was designed to collect information ini-
tially from the registrar of pathological anatomy labora-
tory; and from the medical records of patients in surgery
and gynecology services who receive suspected cases.
The information included: socio-demographic character-
istics, such as age, occupation, economic status, educa-
tion level, residence, ethnic group, marital status and
parity; histo-pathological characteristics, such as location
of the BC, delay between the first symptoms to consult-
ation, nature of the sample, tumour type, tumour grade,
treatment and evolution of the disease (Additional file 1).
Classification criteria
Histology grade was based on Scarff-Bloom-Richardson
grading system [17]. Economic status has been defined
in terms of family income according to international
poverty threshold. Income is poor if it is below 2 dollars
a day, it is moderate between 2 and 4 dollars, good be-
tween 5 and 10 dollars and excellent if it exceeds 10 dol-
lars [18]. The residence is called urban to those living in
Bangui and rural for those living in the provinces (before
diagnosis for cases). Ethnicity was grouped into seven
major ethnic groups of the country.
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Statistical analysis
Data analysis was performed using the Statistical Package
for Social Sciences (SPSS Inc., Chicago, IL, USA) version
20. Descriptive analysis was performed to characterize the
demographic variables of the patients. Mean and standard
deviation (SD) were described for the continuous variables
with normal distribution and ranges for the continuous
variables with skewed distribution. An independent t-test
or nonparametric test was used to determine the differ-
ence between groups. Frequencies and proportions were
used for categorical variables. The differences were deter-
mined by Chi-square test or a Fisher exact test. The ana-
lysis of variance method was used to compare the group
differences. Trend test was used to detect the change
trend of the related variables along with time. Statistical
significance was set at the P value < 0.05.
Results
Socio-demographic characteristics of patients
In total, 174 cases of BC confirmed by pathological anat-
omy service were included in this study from 2003 to
2015. The socio-demographic characteristics of the pa-
tient were shown in Table 1. The age at diagnosis for the
cases ranged from 16 to 90 years with a mean of 45.83
(SD = 13.5) years. The age group (45–54 years) repre-
sented the majority of the study population (29.3%).
Over 69.5% of the sample was housewives with a moder-
ate economic status (56.9%). Less than 14% of the study
population had a level of academic degree and 85.6%
lived in cities. The most represented ethnic groups were
the Yakoma (21.8%), followed by Mandja (19.0%) and
Banda (18.4%). The Mbororo ethnic was a minority with
1.1%. Single occupied 73.6% of the sample, however, a
small proportion (17.9%) is nulliparous (Table 1).
Incidence and mortality rate of breast cancer
According to Fig. 1, the prevalence curve of BC is bimodal
with two peaks at 2005 and 2015. The trend of incidence
and mortality increased with age before 45 years and de-
creased after 55 years (Fig. 2). Three peaks were found
when looked into age-specific incidences. The first peak
appeared at the group of 40–44 years, and then the rate
gradually decreased after 45. The second peak appeared at
the group of 50–54 years and decreased after 55 years but
dramatically increased again in the group 70–74 years and
decreased over 75 years (Fig. 2).
Contrary to the incidence curve, the age-specific mor-
tality had two peaks. The first peak appeared at the
group of 50–54 years and the second was observed in
the group of 70–74 years (Fig. 2). The annual average
crude incidence was 7.49/100,000 women, while mortal-
ity was 6.71/100,000 women. After adjusted by standard
population, the age-adjusted incidence rate for BC was
11.19 (95%, CI: 9.53–12.84) per 100,000 women. On the
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other hand, the age-adjusted death rate for BC was 9.97
(95%, CI: 8.86–12.17) per 100,000 women.
Histo-pathological features
The left breast is mainly affected than the right breast
(12% against 4%). The time between the first symptoms
and the first consultation with a specialist was more than
48 months in 35% and less than 12 months in 30% of cases
(Fig. 3). The majority of samples received and analysed by
the pathological anatomy service consisted of 69% of
lumpectomy followed by 30% breast biopsy (Fig. 4).
The histological trend and grade of the common
pathological types among the patients with BC are pre-
sented in Fig. 5 and Table 2. According to Fig. 5, the
predominant tumour histological patterns were invasive
ductal carcinoma 113 (64.9%), invasive lobular carcin-
oma 17 (9.8%) followed by ductal carcinoma in situ 10
(5.7%) and medullary carcinoma 5 (2.8%). On the other
hand, the histological grade of Scarff Bloom Richardson
(SBR) was available for 28 patients (16.1%). In our
study, SBR III was the main grade in both common
pathological types except for the lobular carcinoma in
situ. In lobular carcinoma in situ and invasive lobular
carcinoma, the proportion of SBR III was low, how-
ever, the proportion of SBR I was higher in lobular car-
cinoma than in situ. Unfortunately, the proportion of
SBR III BC showed no significant increase along with
time (χ2 = 7.06, p = 0.54). The proportion of invasion
of regional lymph node differed significantly among
the common pathological type of BC (χ2 = 24.6, p = 0.02)
as in Table 2. According to Table 3, 166 (95.4%) of patients
underwent surgery, and 159 (91.4%) were on chemother-
apy. Radiology was performed in 53 (30.4%) women. How-
ever, the majority (84.5%) of the cases died instead, and
only 21 (12.1%) remained alive. Note also that 6 (3.4%)
were considered “lost to follow-up” in the investigation.
Discussion
The pathological diagnosis is very problematic in most
African countries at the instance of the CAR. In CAR,
there is only one pathological anatomy service located at
Bangui the capital. This unique pathological anatomy
Fig. 1 Prevalence of breast cancer among women per year from 2003 to 2015
Fig. 2 Age-adjusted Incidence and Death rates for Breast Cancer among Women over 15 years old in Central African Republic from 2003 to 2015
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service does not practice the essential immunohisto-
chemistry to detect hormone receptors. However, for
other molecular studies, this pathological anatomy
service was forced to work with other European or
American laboratories with the corollary examining
tissue blocks stored in more or less good conditions.
Unfortunately, we have no information on the results
of these molecular analyses as the results have never
been made public.
However, during the period of this study, 67.18% of
women breast specimens received at pathological anat-
omy department were malignant. Most patients were in
the age groups of 35 to 44 and 45 to 54 with 28.2% and
29.3% respectively. We can say that the predominant
population found is consistent with some previous stud-
ies carried out worldwide [14, 15, 19, 20]. On the other
hand, it should be noted that the majority of cases were
diagnosed late; more than 48 months later. These find-
ings confirm that BC in African women is characterised
by a younger age at onset, advanced stage at diagnosis,
and /or poor prognosis. For example, in our case, about
one-third (n = 27; 18, 9%) of women with BC are in the
group of younger age (15 to 34 years) and presented
with the disease at an advanced stage. The reasons for
the low sample size (174) and the late presentation of
patients in hospitals include: lack of information and
awareness about BC, lack of education, ignorance of the
disease symptoms, cultural beliefs and stress disease, a
sceptical attitude toward Western medicine and de-
pendence on the traditional medicine. We cannot ig-
nore the low socioeconomic level of the target
population, the lack of access to quality care and a suit-
able deficit insufficient compared to the needs of tech-
nology and the lack of an effective national program for
screening BC to promote weight reduction of this dis-
ease in the CAR population. This contrasts with that of
the developed world where mammography screening
and greater awareness of women had led to an early de-
tection of the disease. The medico-social support ac-
cordingly ultimately results in increased survival rates
of patients.
In addition, worldwide studies reveal that there is a
higher incidence of BC in young women of African ori-
gin living in Western countries [21, 22]. This observa-
tion was confirmed by a study on the data collected
from British women by Bown et al. who demonstrated
that black British women were diagnosed with BC at a
much younger age compared to their white counterparts
[23]. In line with this, in Africa, a study by Ntekim et al.
among young women living in Ibadan, Nigeria has
reached the same conclusion [24].
Regarding the results of our study, the incidence rate
reported for the period 2003 to 2015 is lower than that
described in developed countries and some countries in
Africa and Asia. According to the literature, the overall
incidence of BC has increased in recent decades. It has
reached more than 100 / 100,000 in developed coun-
tries, and more than 9% among American women have
suffered from this disease in their lives [25]. In Asia
and Africa, some countries have also experienced rapid
growth in the incidence of BC. In China, for example,
the reported incidence of BC for the period 2003–2007
was 68.6 / 100,000 in Shanghai and 57.6 / 100,000 in
Beijing [26–28].
However, according to the WHO report in 2012, the in-
cidence of BC is 31.5 / 100, 000 in Cameroon, 22.5 /
100,000 in Egypt, 24.2 / 100,000 in Ghana, 22.8 / 100,000
in Burkina Faso, 19.8 / 100,000 in Haiti and 15.9 / 100,000
in Guinea [4]. Among the population of Reunion Island,
the crude incidence rate of the period of 2005 to 2010 for
20 to 49 aged women was 31.4 / 100,000. This lower inci-
dence of BC in SSA among African women of a certain
age can be explained by lower estrogen prolonged expos-
ure (relatively late age of onset of menstruation, early
pregnancy, the longest breastfeeding by the mother,
Fig. 3 Delay between symptoms to consultation
Fig. 4 Nature of the sample
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multiparty, the rare practice of therapeutic hormone re-
placement during menopause). Thus, in a case-control
study conducted in Nigeria by Huo et al. it has been dem-
onstrated that multiparous women and those who practice
breastfeeding for more than 12 months or more had a
lower incidence of BC [29]. Some authors have reported
similar results in South Africa [30]. But in a medical cen-
ter in Nigeria in 1992, Ihekwala et al. have not found the
same relationship [31]. According to the evolution of life-
styles, it is foreseeable that the epidemiology of BC in SSA
would change in the coming decades. The change would
be mainly due to a significant improvement in the level of
education of women and their practice (use of oral contra-
ception, first pregnancy before age 30, and abstention of
certain substances that may cause BC, use of hormonal
substitutions, obesity and physical inactivity).
On the other hand, the cumulative prevalence of BC in
all cases of cancer diagnosed during the period 2003 to
2015 is 15.27%. This proportion is slightly below in coun-
tries such as Niger (19.28%), Madagascar (22.4%), Reunion
Island (40%), Loire-Atlantique (24%), Isere (23.8%) among
Caucasian - US (21%) and African American in the US
(33.1%) [32, 33]. Moreover, the study indicates that a
significant increase in BC incidence was observed among
women 50 to 54 years. These results are different from
those described by Marianne Dubard-Gault (2014) in
Reunion Island and Bodmer et al. (2013) in Switzerland,
where the incidence of BC has increased most in young
women than those over 40 years old [34, 35]. Similarly in
Europe during the period 1990 to 2009, incidence had in-
creased among women aged under 35 years than those
aged 35 to 39 years [35]. However, in the US, the inci-
dence among young women under 40 years had increased
by 1.47% per year [36].
Thus, some authors have reported that African women
living in the urban areas lose the protective benefit of
low estrogen exposure, age before their first pregnancy
and menopause [37]. The same observation has been re-
ported in a study by Ben Gobrane et al. and Ekortard et
al. [38, 39]. These studies also explain the low propor-
tion of patients living in rural area of the cohort. It could
be also linked to the lack of qualified health workers at
the peripheral level for refer them to the referral centers.
Another reason was the distance from the capital Bangui
where the only screening laboratory is available but in-
considerate of the low socioeconomic level of the CAR
Fig. 5 Distribution of tumours according to the histological type
Table 2 Regional lymph node invasion of the common pathological type of breast cancer among all the patients
Type of Breast Cancer N1 N2 N3 χ2 P value
N (%) N (%) N (%)
Ductal carcinoma in situ 107 (98.2) 2 (1.8) 0 (0.0) 24.6 0.02
Invasive ductal carcinoma 7 (87.5) 0 (0.0) 1 (12.5)
Invasive lobular carcinoma 1 (50.0) 1 (50.0) 0 (0.0)
Mucinous carcinoma 2 (100.0) 0 (0.0) 0 (0.0)
Endocrine carcinoma of the breast 1 (100.0) 0 (0.0) 0 (0.0)
χ2 and p-value were calculated by using Fisher’s exact chi square
The proportion of invasion of regional lymph node differed significantly among the common pathological type of BC (χ2=24.6, p=0.02)
Freq Frequency; χ2 chi square, SD Standard Deviation, N Lymph Node
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population. Sometimes people of the rural area which
had the opportunity to go to the hospital are confronted
by the weight of the traditional belief, which may justify
their late submission to the service of modern medicine.
Also, note that the significant increase of BC cases in
the age group 45 to 54 confirm the priori literature indi-
cating that BC is a disease of mature women.
The trend of mortality varies in proportion to the fre-
quency in this study. However, the study noted a signifi-
cant increase in the age group of 50 to 54. This rate is
similar to that of Gabon (10.9 / 100,000), which is more
than that of China (6.2 / 100,000) but lower than that of
Cameroon, Egypt, Ghana and Haiti (25.7; 21.6; 18.5 and
14.2%’s per 100,000 respectively) [4]. According to the
literature, the experiences of early detection of BC and
starting treatment when the cancer is at a localized
stage, significantly improve the prognosis of the disease
and also contribute to a decline in mortality due to ill-
ness [40]. However, the high rates of BC mortality in this
study could be attributable to delayed diagnosis or a lack
of financial resources for health care, as published in the
report of the World Bank in 2015. In fact, that report
showed that more than 66% of the CAR population lived
below the poverty line with 338.728 dollars per capita
per year [41].
In our study, BC diagnosis is established after examin-
ation of parts of lumpectomy or breast biopsy. However,
we noted that malignant tumours predominate in the left
breast as reported in previous studies by Koffi et al. in
CAR and Tre-Yavo et al. in Senegal respectively [14, 42].
Other studies, rather claim a predominance of cancer in
the right breast [43]. The frequency of bilateral forms in
our series is less than Mengué S. in Gabon or Khairy et al.
in Saudi Arabia [43, 44]. Therefore, we do not have suffi-
cient scientific evidence to justify the disparity of this BC
location in CAR women.
In addition, the most common morphology of the BC
(invasive ductal carcinoma) in our study was slightly
below some studies by Darré et al. in Togo and Echi-
mane et al. in Ivory Coast, which respectively reported
96 and 97% for cancers and 2.6 and 2.04% for sarcomas
[45, 46]. While Engbang et al. in Cameroon and Der
Muonir et al. in Ghana noted 74.3 and 91.6% of invasive
ductal carcinomas followed by 4.3 and 3.1% of invasive
lobular carcinoma [47, 48]. The same trends have been
observed in previous studies by Koffi et al. in Bangui
and have reported the prevalence of invasive ductal car-
cinoma followed by invasive lobular carcinoma [14].
Histoprognostic grade SBR studied in this series re-
vealed a high proportion of grade III followed by grade II
and grade I. In 2006, similar proportions were reported by
Ohene et al. in Ghana [49]. These authors had found
53.7% of grade III tumors, 31.5% of grade II tumors and
14.8% of grade I tumor [49]. However, some studies have
shown various proportions. A study by Essiben et al.
found a trend in the following order of frequency:
grades II, I and III to the Gynecological Obstetric and
Pediatric Hospital in Yaoundé [50]. In 2004, Koffi et al.
was in Bangui, noted that the grade II tumors were
most significant with 58.4% of cases, while the tumor
grade I and II were in the same proportion (20.8%)
[14]. These findings are contrary to those reported in
Libreville by Meye et al. that, the grade II held the last
position after classes I and III [51].
Our study found that there is a statistically significant
correlation between age and education level (X2 = -0.155,
p = 0.04). By cons, age and education level have no stat-
istical relationship with the type of cancer (SBR). Simi-
larly, between the women lived in rural area and the
time at diagnosis. Even then, the chi-square of Pearson
and Fisher test revealed no significant difference be-
tween age group and time for consultation of the doc-
tor or type of cancer (SBR). This explains that early or
late detection is independent of the level of education
or age. But apparently, the level of knowledge about the
symptoms of the disease and access to health care cen-
ter is essential.
According to several studies, the conservative treat-
ment of BC only affects some patients in SSA and only a
few centers perform the sentinel lymph node technique
[52, 53]. The most common surgical treatment is mast-
ectomy with systematic lymphadenectomy. However, in
our study, 95.2% of patients were treated with surgery
and 91.4% with complementary chemotherapy. Our re-
sults were well above the studies by Gakwaya et al. were
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only 26% of patients received chemotherapy and
Seredouma et al. of whom 66.3% had surgery [13, 54].
According to the socioeconomic context of the CAR,
chemotherapy, although indicated for the treatment of
BC, the prescription of anticancer drugs is often con-
fronted by the availability of molecules on the one hand
and the possibilities of financing by the patient. Despite
the large number of patients receiving chemotherapy,
only 21 (12.1%) of the patients were able to complete
their treatment cycles. A cost of chemotherapy was esti-
mated at $ 260, resulting in the cost of chemotherapy
being varied from $ 1040 to $ 1560. This cost was well
above the financial income of the patients according to
the report of World Bank 2015 [41]. This justifies the
difficulties of access to chemotherapy treatments whose
drugs are not available in Bangui [55].
However, approximately 58.7% of patients in this series
had no education or stopped at the elementary level. In
addition, over 69% of the cohorts were housewives
whose socio-economic status is low. Due to low levels of
formal education, there is a lack of awareness of early
warning signs of BC. Therefore, many patients died after
the late diagnosis. Our study did not have sufficient in-
formation to calculate the survival rate of each positively
diagnosed patient.
Some limitations of this study need to be addressed.
First, it should be known that there are no population
registers for cancer in CAR. Therefore, the incidence of
BC per year could not be determined. The number of
BC cases subjected to immune-histochemical analysis
was not specified. The most concern is that there is no a
broad national screening program for BC implemented
in the country. From the points of view of the repre-
sentativeness of this study data, the CAR has only patho-
logical anatomy service for BC diagnosis and one
cancerology unit for the treatment of all cases of the
whole national territory. However, despite the small
sample size, we believe that the results of this study can
be extrapolated to the general target population of the
CAR. Second, due to the retrospective nature of this
study, a consecutive number of our data (14%) was ex-
cluded for lack of information as a result of the poor ar-
chives management. Third, a lack of information on the
death date of patients which would allow us to calculate
the survival rate after diagnosis. Nevertheless, we are
convinced that the results and limitations of this study
will contribute to the ongoing research in the field of BC
in CAR and our comments would be replicated and veri-
fied on larger populations.
Conclusion
According to the results of our study, BC disease is com-
mon and affected most of the women. Epidemiological
trends are more or less common to those of developing
countries, with a predominance of invasive ductal car-
cinoma. However, most of the women studied live in an
urban area and developed the disease in advanced stage.
It is obvious that the implementation of the National
Cancer Registry could facilitate the study of the evolu-
tion of the tendency of cancer by age group in the fu-
ture, to achieve an appropriate screening system and
provide training to people at risk. This will help health
officials monitor the disease in the community. Given
that knowledge of BC trends and its common morpholo-
gies in the country can help to reduce its incidence rate
in the population, via good planning.
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